Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients

Clinical Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles